Iodixanol: Risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations

被引:16
|
作者
Cheruvu, Bharadwaj [1 ]
Henning, Kathleen [1 ]
Mulligan, Janine [1 ]
Klippenstein, Donald [1 ]
Lawrence, David [1 ]
Gurtoo, Lalit [1 ]
Gottlieb, Ronald H. [1 ]
机构
[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
关键词
computed tomography; contrast-induced nephropathy;
D O I
10.1097/rct.0b013e31802e29d9
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective: To assess the risk of contrast-induced nephropathy in cancer patients with underlying renal insufficiency receiving the iso-osmolar intravenous contrast agent iodixanol for diagnostic computed tomography (CT) examinations. Methods: Institutional review board approval was obtained with waiver of informed consent. Our study was a retrospective evaluation comparing the incidence of contrast-induced nephropathy in consecutive patients with underlying renal insufficiency undergoing diagnostic CT examinations receiving iodixanol from November 2003 to June 2005 with a comparison group of patients with normal baseline renal function over the same period. Renal insufficiency was considered a serum creatinine level more than 1.2 mg/dL in females and more than 1.5 mg/dL in males. Contrast nephropathy was considered an absolute elevation of 0.5 mg/dL or 25% elevation in serum creatinine level. Results: In the group of patients receiving iodixanol with underlying renal insufficiency (189 patients), 9.0% developed contrast nephropathy (P = 0.015) with 4.8% of patients developing irreversible renal damage (P = 0.03). This compared with 4.9% of patients receiving iodixanol (185 patients) and 3.1% of patients receiving iohexol (194 patients) with normal baseline renal function developing contrast nephropathy (P = 0.38) with 3.2% of the iodixanol patients and 1.0% of the iohexol patients developing irreversible renal damage (P = 0.13). Conclusions: The risk of contrast-induced nephropathy is significantly higher in patients with underlying renal insufficiency receiving iodixanol than that for patients with normal baseline renal function, but this should not serve as an absolute contraindication for these patients to receive intravenous iodinated contrast for diagnostic CT examinations particularly in patients with life-threatening clinical questions in which contrasted CT may provide valuable information.
引用
收藏
页码:493 / 498
页数:6
相关论文
共 31 条
  • [1] Contrast-induced nephropathy in patients with active cancer undergoing contrast-enhanced computed tomography
    Seok-In Hong
    Shin Ahn
    Yoon-Seon Lee
    Won Young Kim
    Kyung Soo Lim
    Jae Ho Lee
    Jae-Lyun Lee
    Supportive Care in Cancer, 2016, 24 : 1011 - 1017
  • [2] Contrast-induced nephropathy in patients with active cancer undergoing contrast-enhanced computed tomography
    Hong, Seok-In
    Ahn, Shin
    Lee, Yoon-Seon
    Kim, Won Young
    Lim, Kyung Soo
    Lee, Jae Ho
    Lee, Jae-Lyun
    SUPPORTIVE CARE IN CANCER, 2016, 24 (03) : 1011 - 1017
  • [3] Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography - A double-blind comparison of iodixanol and iopamidol
    Barrett, Brendan J.
    Katzberg, Richard W.
    Thomsen, Henrik S.
    Chen, Nan
    Sahani, Dushyant
    Soulez, Gilles
    Heiken, Jay P.
    Lepanto, Luigi
    Ni, Zhou-Hui
    Nelson, Rendon
    INVESTIGATIVE RADIOLOGY, 2006, 41 (11) : 815 - 821
  • [4] Evaluation of the nephrotoxicity of iodixanol in patients with predisposing factors to contrast medium induced nephropathy referred for contrast enhanced computed tomography
    Sandstede, Joern J. W.
    Roth, Anne
    Machann, Wolfram
    Kaupert, Christine
    Hahn, Dietbert
    EUROPEAN JOURNAL OF RADIOLOGY, 2007, 63 (01) : 120 - 123
  • [5] Contrast-induced nephropathy in patients with renal insufficiency undergoing contrast-enhanced MDCT
    Murakami, Ryusuke
    Hayashi, Hiromitsu
    Sugizaki, Ken-ichi
    Yoshida, Tamiko
    Okazaki, Emi
    Kumita, Shin-ichiro
    Owan, Chojin
    EUROPEAN RADIOLOGY, 2012, 22 (10) : 2147 - 2152
  • [6] Anemia and the risk of contrast-induced nephropathy in patients with renal insufficiency undergoing contrast-enhanced MDCT
    Murakami, Ryusuke
    Kumita, Shin-ichiro
    Hayashi, Hiromitsu
    Sugizaki, Ken-ichi
    Okazaki, Emi
    Kiriyama, Tomonari
    Hakozaki, Kenta
    Tani, Hitomi
    Miki, Izumi
    Takeda, Minako
    EUROPEAN JOURNAL OF RADIOLOGY, 2013, 82 (10) : E521 - E524
  • [7] Factors affecting the incidence of contrast-induced nephropathy in patients undergoing computed tomography
    Heras Benito, M.
    Garrido Blazquez, M.
    Gomez Sanz, Y.
    Bernardez Mardomingo, M.
    Ruiz Cacho, J.
    Rodriguez Recio, F. J.
    Fernandez-Reyes Luis, M. J.
    RADIOLOGIA, 2018, 60 (04): : 324 - 329
  • [8] Contrast-induced nephropathy in patients at risk of renal failure undergoing computed tomography: Systematic review and meta-analysis of randomized controlled trials
    Arana, Estanislao
    Catala-Lopez, Ferran
    MEDICINA CLINICA, 2010, 135 (08): : 343 - 350
  • [9] Contrast-induced nephropathy in patients with renal insufficiency undergoing contrast-enhanced MDCT
    Ryusuke Murakami
    Hiromitsu Hayashi
    Ken-ichi Sugizaki
    Tamiko Yoshida
    Emi Okazaki
    Shin-ichiro Kumita
    Chojin Owan
    European Radiology, 2012, 22 : 2147 - 2152
  • [10] Low-Contrast Dose Protection Protocol for Diagnostic Computed Tomography in Patients at High-Risk for Contrast-Induced Nephropathy
    Kidoh, Masafumi
    Nakaura, Takeshi
    Awai, Kazuo
    Matsunaga, Yoshinari
    Tanoue, Kenichiro
    Harada, Kazunori
    Uemura, Shouzaburou
    Yamashita, Yasuyuki
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2013, 37 (02) : 289 - 296